NCT06281132

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

A Randomized, Open-label, Single Dose, 4-period Replicate Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-341 in Healthy Volunteers Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The objective was to evaluate and compare the pharmacokinetic profiles and safety after administration of test drug (CKD-341) and reference drugs (D956) in healthy adults.

Detailed description

A randomized, open-label, single dose, 4-period replicate crossover study in healthy adults under fasting conditions

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-341, D956	A single dose of 1 tablet under fasting condition

Timeline

• Start date: 2024-03-22
• Primary completion: 2024-05-07
• Completion: 2024-05-14
• First posted: 2024-02-28
• Last updated: 2024-05-28

Locations

1 site across 1 country: South Korea